Journal of Gastric Cancer

  • 제10권3호
  • /
  • Pages.111-117
  • /
  • 2010
  • /
  • 2093-582X(pISSN)
  • /
  • 2093-5641(eISSN)
대한위암학회 (The Korean Gastric Cancer Association)
권호 표지
DOI QR코드

DOI QR Code

Utility of Surgical Resection in the Management of Metachronous Krukenberg's Tumors of Gastric Origin

  • Kim, Gwon-Sik (Department of Surgery, Division of Gastric Surgery, Seoul Asan Medical Center, College of Medicine, Ulsan University) ;
  • Kim, Kap-Choong (Department of Surgery, Division of Gastric Surgery, Seoul Asan Medical Center, College of Medicine, Ulsan University) ;
  • Kim, Beom-Su (Department of Surgery, Division of Gastric Surgery, Seoul Asan Medical Center, College of Medicine, Ulsan University) ;
  • Kim, Tae-Hwan (Department of Surgery, Division of Gastric Surgery, Seoul Asan Medical Center, College of Medicine, Ulsan University) ;
  • Yook, Heong-Hwan (Department of Surgery, Division of Gastric Surgery, Seoul Asan Medical Center, College of Medicine, Ulsan University) ;
  • Oh, Sung-Tae (Department of Surgery, Division of Gastric Surgery, Seoul Asan Medical Center, College of Medicine, Ulsan University) ;
  • Kim, Byung-Sik (Department of Surgery, Division of Gastric Surgery, Seoul Asan Medical Center, College of Medicine, Ulsan University)
  • 투고 : 2010.06.08
  • 심사 : 2010.09.01
  • 발행 : 2010.09.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: The aim of this study was to determine the prognostic factors and the significance of metastatectomy for Krukenberg's tumors of gastric origin.Materials and Methods: Among the patient who underwent gastric surgery from 1992 through 2005, 90 female patients with Krukenberg's tumors of gastric origin were identified. We retrospectively reviewed the clinicopathologic characteristics, prognostic factors, and treatments for primary gastric cancer. We also investigated the prognostic risk factors for the onset of metachronous Krukenberg's tumors and the survival time of patients who underwent an operation for metachronous Krukenberg's tumors. Results: The presence of a synchronous Krukenberg's tumor (mean survival time=17.6 months, P<0.01), peritoneal seeding (14.5 months, P<0.01), and non-curative resection (15.1 months, P<0.01), were statistically significant prognostic factors for survival time in female patients with gastric cancer. The stage of primary gastric cancer (P=0.049) and lymph node metastasis (P=0.011) were statistically significant risk factors for recurrence time of a metachronous Krukenberg's tumor. In the metachronous Krukenberg's tumor group (n=53), the mean survival time of the metastatectomy group (n=46, 43.2 months, P=0.012) was longer than that in the chemotherapy or conservative treatment groups (n=7 and 24 months, respectively). Metastatectomy, presense or abscence of residual tumor and extent of residual tumor were significant prognostic factors for survival time in female patients with metachronous Krukenberg's tumor of gastric origin. Conclusions: A close observation and evaluation with ultrasound or computed tomography is necessary in female patients with advanced gastric cancer to detect a metachronous Krukenberg's tumor as soon as possible. The surgeon must operate more aggressively in patients with metachronous Krukenberg's tumors.

키워드

참고문헌

  1. Krukenberg F. Uber das Fibrosarcoma ovarii mucocellulare (carcinomatoses). Arch Gynakol 1896;50:287-321. https://doi.org/10.1007/BF01700650
  2. Woodruff JD, Novak ER. The Krukenberg tumor: study of 48 cases from the ovarian tumor registry. Obstet Gynecol 1960;15:351-360.
  3. McDUFF HC. Metastatic Krukenberg tumor of the ovary, primary in the breast; with six year survival. R I Med J 1950;33:589-593.
  4. Khunamornpong S, Suprasert P, Chiangmai WN, Siriaunkgul S. Metastatic tumors to the ovaries: a study of 170 cases in northern Thailand. Int J Gynecol Cancer 2006;16(Suppl 1):132-138. https://doi.org/10.1111/j.1525-1438.2006.00302.x
  5. Cho SJ, Kwon SJ, Kwon OJ, Jung PJ, Lee KS, Kwak JY, et al. Clinicopathological analysis of krukenberg tumor arising from stomach cancer. J Korean Surg Soc 1998;55:826-832.
  6. Webb MJ, Decker DG, Mussey E. Cancer metastatic to the ovary: factors infl uencing survival. Obstet Gynecol 1975;45:391-396.
  7. Schlagenhaufer F. Uber das metastatische ovarial carcinoma nach Krebs des Magens, Darmes und anderer Bauchorgane. Monatsschr Geburtshilfe Gynakol 1902;1:485-528.
  8. Kobayashi O, Sugiyama Y, Cho H, Tsuburaya A, Sairenji M, Motohashi H, et al. Clinical and pathological study of gastric cancer with ovarian metastasis. Int J Clin Oncol 2003;8:67-71. https://doi.org/10.1007/s101470300012
  9. Duarte I, Llanos O. Patterns of metastases in intestinal and diff use types of carcinoma of the stomach. Hum Pathol 1981;12:237-242. https://doi.org/10.1016/S0046-8177(81)80124-4
  10. Hale RW. Krukenberg tumor of the ovaries. A review of 81 records. Obstet Gynecol 1968;32:221-225.
  11. McGill FM, Ritter DB, Rickard CS, Kaleya RN, Wadler S, Greston WM, et al. Krukenberg tumors: can management be improved? Gynecol Obstet Invest 1999;48:61-65. https://doi.org/10.1159/000010136
  12. Kim NK, Kim HK, Park BJ, Kim MS, Kim YI, Heo DS, et al. Risk factors for ovarian metastasis following curative resection of gastric adenocarcinoma. Cancer 1999;85:1490-1499. https://doi.org/10.1002/(SICI)1097-0142(19990401)85:7<1490::AID-CNCR9>3.0.CO;2-G
  13. Hirno M, Taniyama K, Matsuki K, Nakagami K, Nimoto M, Hattori T. Clinico-pathologic studies on ovarian metastasis from gastric cancer. Jpn J Surg 1983;13:25-31. https://doi.org/10.1007/BF02469686
  14. Kakushima N, Kamoshida T, Hirai S, Hotta S, Hirayama T, Yamada J, et al. Early gastric cancer with Krukenberg tumor and review of cases of intramucosal gastric cancers with Krukenberg tumor. J Gastroenterol 2003;38:1176-1180. https://doi.org/10.1007/s00535-003-1227-3
  15. Kim HK, Heo DS, Bang YJ, Kim NK. Prognostic factors of Krukenberg's tumor. Gynecol Oncol 2001;82:105-109. https://doi.org/10.1006/gyno.2001.6210
  16. Jiang R, Tang J, Cheng X, Zang RY. Surgical treatment for patients with different origins of Krukenberg tumors: outcomes and prognostic factors. Eur J Surg Oncol 2009;35:92-97. https://doi.org/10.1016/j.ejso.2008.05.006
  17. Studzinski Z, Zajewski W. Bilateral metastatic ovarian tumors (Krukenberg's tumors) in the course of stomach cancer. Arch Gynecol Obstet 2002;267:95-97. https://doi.org/10.1007/s00404-001-0259-2
  18. Cheong JH, Hyung WJ, Chen J, Kim J, Choi SH, Noh SH. Sur gical management and outcome of metachronous Krukenberg tumors from gastric cancer. J Surg Oncol 2004;87:39-45. https://doi.org/10.1002/jso.20072
  19. Kim JD, Yook JH, Kim YM, Choi WY, Kim YJ, Lim JT, et al. Clinical analysis of 61 krukenberg tumors. J Korean Gastric Cancer Assoc 2004;4:126-130. https://doi.org/10.5230/jkgca.2004.4.2.126
  20. Kim YS, Lee SH, Choi KH. Effect of radical removal of primary and metastatic lesions in gastric cancer with peritoneal seeding. J Korean Gastric Cancer Assoc 2001;1:136-143. https://doi.org/10.5230/jkgca.2001.1.3.136